DNA methyltransferase inhibition reduces inflammation-induced colon tumorigenesis

dc.contributor.authorMaiuri, Ashley R.
dc.contributor.authorSavant, Sudha S.
dc.contributor.authorPodicheti, Ram
dc.contributor.authorRusch, Douglas B.
dc.contributor.authorO’Hagan, Heather M.
dc.contributor.departmentMedical and Molecular Genetics, School of Medicineen_US
dc.date.accessioned2020-11-03T13:38:35Z
dc.date.available2020-11-03T13:38:35Z
dc.date.issued2019-06-26
dc.description.abstractChronic inflammation is strongly associated with an increased risk of developing colorectal cancer. DNA hypermethylation of CpG islands alters the expression of genes in cancer cells and plays an important role in carcinogenesis. Chronic inflammation is also associated with DNA methylation alterations and in a mouse model of inflammation-induced colon tumorigenesis, we previously demonstrated that inflammation-induced tumours have 203 unique regions with DNA hypermethylation compared to uninflamed epithelium. To determine if altering inflammation-induced DNA hypermethylation reduces tumorigenesis, we used the same mouse model and treated mice with the DNA methyltransferase (DNMT) inhibitor decitabine (DAC) throughout the tumorigenesis time frame. DAC treatment caused a significant reduction in colon tumorigenesis. The tumours that did form after DAC treatment had reduced inflammation-specific DNA hypermethylation and alteration of expression of associated candidate genes. When compared, inflammation-induced tumours from control (PBS-treated) mice were enriched for cell proliferation associated gene expression pathways whereas inflammation-induced tumours from DAC-treated mice were enriched for interferon gene signatures. To further understand the altered tumorigenesis, we derived tumoroids from the different tumour types. Interestingly, tumoroids derived from inflammation-induced tumours from control mice maintained many of the inflammation-induced DNA hypermethylation alterations and had higher levels of DNA hypermethylation at these regions than tumoroids from DAC-treated mice. Importantly, tumoroids derived from inflammation-induced tumours from the DAC-treated mice proliferated more slowly than those derived from the inflammation-induced tumours from control mice. These studies suggest that inhibition of inflammation-induced DNA hypermethylation may be an effective strategy to reduce inflammation-induced tumorigenesis.en_US
dc.identifier.citationMaiuri, A. R., Savant, S. S., Podicheti, R., Rusch, D. B., & O’Hagan, H. M. (2019). DNA methyltransferase inhibition reduces inflammation-induced colon tumorigenesis. Epigenetics, 14(12), 1209–1223. https://doi.org/10.1080/15592294.2019.1634986en_US
dc.identifier.issn1559-2294en_US
dc.identifier.urihttps://hdl.handle.net/1805/24253
dc.language.isoen_USen_US
dc.publisherTaylor & Francisen_US
dc.relation.isversionof10.1080/15592294.2019.1634986en_US
dc.relation.journalEpigeneticsen_US
dc.sourcePMCen_US
dc.subjectInflammationen_US
dc.subjectDNA methylationen_US
dc.subjectcolon canceren_US
dc.subjectdecitabineen_US
dc.subjectinterferon signalingen_US
dc.titleDNA methyltransferase inhibition reduces inflammation-induced colon tumorigenesisen_US
ul.alternative.fulltexthttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791707/en_US
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
kepi-14-12-1634986.pdf
Size:
3.37 MB
Format:
Adobe Portable Document Format
Description:
Main article
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: